These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3194977)

  • 1. African horse sickness in Zimbabwe: 1972 to 1981.
    Blackburn NK; Swanepoel R
    Trop Anim Health Prod; 1988 Aug; 20(3):169-76. PubMed ID: 3194977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observations on antibody levels associated with active and passive immunity to African horse sickness.
    Blackburn NK; Swanepoel R
    Trop Anim Health Prod; 1988 Nov; 20(4):203-10. PubMed ID: 3238767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals.
    Crafford JE; Lourens CW; Gardner IA; Maclachlan NJ; Guthrie AJ
    Equine Vet J; 2013 Sep; 45(5):604-7. PubMed ID: 23294121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of African horse sickness antibodies in animals of various species in Egypt.
    Awad FI; Amin MM; Salama SA; Aly MM
    Bull Anim Health Prod Afr; 1981 Sep; 29(3):285-7. PubMed ID: 7201860
    [No Abstract]   [Full Text] [Related]  

  • 5. A serological survey of African horse sickness in Botswana.
    Hyera JM; Baipoledi EK
    J S Afr Vet Assoc; 2008 Mar; 79(1):44-5. PubMed ID: 18678192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sero-prevalence and sero-incidence of African horse sickness and equine encephalosis in selected horse and donkey populations in Zimbabwe.
    Gordon SJG; Bolwell C; Rogers CW; Musuka G; Kelly P; Guthrie A; Mellor PS; Hamblin C
    Onderstepoort J Vet Res; 2017 May; 84(1):e1-e5. PubMed ID: 28582979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
    van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
    Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A competitive ELISA for the detection of group-specific antibodies to African horse sickness virus.
    Hamblin C; Graham SD; Anderson EC; Crowther JR
    Epidemiol Infect; 1990 Apr; 104(2):303-12. PubMed ID: 2108871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African horse sickness virus antibodies in Cyprus--1971-72.
    Parker J
    Vet Rec; 1974 Apr; 94(16):370-3. PubMed ID: 4428592
    [No Abstract]   [Full Text] [Related]  

  • 11. Descriptive epidemiology of African horse sickness in Zimbabwe.
    Gordon S; Bolwell C; Rogers C; Guthrie A; Magunda F; Hove P
    Onderstepoort J Vet Res; 2013 May; 80(1):578. PubMed ID: 23718258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak investigation and molecular characterization of African horse sickness virus circulating in selected areas of Ethiopia.
    Ayelet G; Derso S; Jenberie S; Tigre W; Aklilu N; Gelaye E; Asmare K
    Acta Trop; 2013 Aug; 127(2):91-6. PubMed ID: 23567554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemagglutination-inhibiting antibodies against African horse sickness virus in domestic animals in Nigeria.
    Baba SS; Olaleye OD; Ayanbadejo OA
    Vet Res; 1993; 24(6):483-7. PubMed ID: 8111431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: AHS vaccine.
    Dvies FG
    Vet Rec; 1976 Jan; 98(2):36. PubMed ID: 1258291
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
    van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
    Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
    Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
    Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African horse sickness virus antibodies in northern Nigeria 1974--1975.
    Parker J; Armstrong RM
    Res Vet Sci; 1977 May; 22(3):274-80. PubMed ID: 877421
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
    van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
    Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.